Blood Group Typing Market by Techniques, Test Type, Product, End-User

List of Tables

[193 Pages Report] The Blood Group Typing Market size was estimated at USD 3.37 billion in 2023 and expected to reach USD 3.63 billion in 2024, at a CAGR 7.82% to reach USD 5.72 billion by 2030.

Blood group typing, also known as blood typing or blood classification, is a crucial process in transfusion medicine and transplantation. It involves identifying specific antigens, proteins, and carbohydrates on the surface of red blood cells (RBCs) and determining an individual's blood group. The increasing demand for safe blood transfusion practices worldwide is one of the primary factors contributing to the market growth. This demand arises due to a growing prevalence of chronic diseases that require frequent blood transfusions. However, high costs associated with advanced testing techniques, such as molecular assays, limit their adoption, particularly in low-resource settings. A lack of skilled professionals capable of operating advanced instruments is another critical challenge th industry faces. Additionally, government initiatives improve healthcare infrastructure, and increased investment from private organizations presents opportunities for market players. Adopting automation technologies, including Next-Generation Sequencing (NGS), can significantly enhance throughput capabilities while reducing human errors during testing.

KEY MARKET STATISTICS
Base Year [2023]	USD 3.37 billion
Estimated Year [2024]	USD 3.63 billion
Forecast Year [2030]	USD 5.72 billion
CAGR (%)	7.82%

Techniques: Increasing adoption of assay-based and massively Parallel Sequencing techniques

Assay-based techniques are widely used for blood group typing, offering rapid and accurate results. They involve using reagents to detect specific antigens on red blood cells' surfaces using serological or molecular methods. Massively Parallel Sequencing (MPS), or Next-Generation Sequencing (NGS), is an advanced technique that allows simultaneous analysis of multiple genomic regions. Microarray technology is a high-throughput method utilized in genomics research that enables simultaneous analysis of various genes or genomic regions.

Test Type: Rapid emergence of ABO blood tests and human leukocyte antigen typing tests to detect the antigens

ABO blood tests are the most basic and widely used method for identifying an individual's blood type (A, B, AB, or O). These tests detect the presence of A and B antigens on red blood cells and corresponding antibodies in plasma. Antibody screening tests help identify clinically significant antibodies in an individual's plasma that may cause adverse reactions during transfusions or organ transplants. Antigen typing tests determine the presence or absence of specific antigens on red blood cells beyond A and B antigens. Cross-matching series tests are performed to ensure donor and recipient blood samples' compatibility directly. Human leukocyte antigen (HLA) Typing is crucial for determining compatibility in organ transplantation by identifying matching HLA molecules between donors and recipients.

Product: Significant use of consumables and instruments in blood group typing services

Consumables are essential materials used in blood group typing to identify and differentiate the various blood groups. The need for consumables has increased due to the demand for accurate and efficient blood group testing for transfusions, prenatal care, organ transplants, and research. Instruments utilized in blood group typing involve devices such as analyzers, cell sorters, microscopes, centrifuges, liquid handlers, and pipettes that enable precise measurement and analysis of samples with high throughput capacity. Blood group typing services encompass testing, consulting, training, and outsourcing solutions that aid hospitals, diagnostic centers, blood banks, and research institutes in managing blood grouping-related activities.

End-User: Emerging use of blood group typing services in clinical laboratories and hospitals

Blood banks are crucial in the healthcare industry as they collect, store, and distribute blood and blood components to hospitals and clinics. Clinical laboratories conduct diagnostic tests for disease detection, monitoring, prevention, or treatment strategies. Blood group typing is essential for prenatal screening, organ transplantation compatibility assessment, or diagnosis of certain genetic conditions. Hospitals require blood group typing services primarily for transfusion purposes and organ transplantation procedures.

Regional Insights

In the Americas, the U.S. and Canada significantly increased the adoption of blood group typing owing to its advanced healthcare infrastructure and huge demand for blood transfusions. Key players have recently invested in research initiatives such as the NIH-funded National Blood Donor Project. In Canada, a rise in government funding for healthcare organizations is driving demand for blood group typing technologies. The Asia-Pacific region is encountering substantial growth due to increased government spending on healthcare and advancements in medical technologies. In China, patent filings related to blood group typing have surged, indicating strong research and market potential. Japan's aging population and India's rising awareness of blood-related disorders drive the need for accurate and efficient blood typing solutions. In Europe, growing investments in biotechnology and life sciences fuel market growth. The EU's Horizon 2020 program has prioritized personalized medicine research through initiatives 'Towards Next-Generation ICTs for Health.' The Middle East and Africa region face unique challenges from their diverse populations and health disparities. However, an increasing focus on improving healthcare access creates opportunities for blood group typing providers.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Group Typing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Group Typing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Group Typing Market, highlighting leading vendors and their innovative profiles. These include Agena Bioscience, Inc., Atlas Medical GmbH, AXO Science SAS, BAG Health Care GmbH, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc, Biorex Diagnostics, Cardinal Health, Genome Diagnostics B.V., Grifols, S.A., Hemo bioscience, Inc., Lorne Laboratories Limited, Merck KGaA, Quotient Suisse SA, Rapid Labs Ltd, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Group Typing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Techniques
- Assay-Based Techniques
- Massively Parallel Sequencing
- Microarray

Test Type
- ABO Blood Tests
- Antibody Screening
- Antigen Typing
- Cross-Matching Series
- Human Leukocyte Antigen Typing

Product
- Consumables
- Instruments
- Services

End-User
- Blood Banks
- Clinical Laboratories
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Group Typing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Group Typing Market?

3. What are the technology trends and regulatory frameworks in the Blood Group Typing Market?

4. What is the market share of the leading vendors in the Blood Group Typing Market?

5. Which modes and strategic moves are suitable for entering the Blood Group Typing Market?

Product Code: MRR-437D459582E9

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing cases of road accidents, emergencies, and trauma
  - 5.1.1.2. Rising adoption of blood group typing in forensic sciences
  - 5.1.1.3. Strict regulatory standards regarding blood transfusion
- 5.1.2. Restraints
  - 5.1.2.1. Lack of awareness and skilled professional
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements and developments in the blood group typing systems
  - 5.1.3.2. Increasing R&D activities and product innovations in blood group typing
- 5.1.4. Challenges
  - 5.1.4.1. Risk associated with transmissible diseases
5.2. Market Segmentation Analysis
- 5.2.1. Techniques: Increasing adoption of assay-based and massively Parallel Sequencing techniques
- 5.2.2. Test Type: Rapid emergence of ABO blood tests and human leukocyte antigen typing tests to detect the antigens
- 5.2.3. Product: Significant use of consumables and instruments in blood group typing services
- 5.2.4. End-User: Emerging use of blood group typing services in clinical laboratories and hospitals
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Blood Group Typing Market, by Techniques

6.1. Introduction
6.2. Assay-Based Techniques
6.3. Massively Parallel Sequencing
6.4. Microarray

7. Blood Group Typing Market, by Test Type

7.1. Introduction
7.2. ABO Blood Tests
7.3. Antibody Screening
7.4. Antigen Typing
7.5. Cross-Matching Series
7.6. Human Leukocyte Antigen Typing

8. Blood Group Typing Market, by Product

8.1. Introduction
8.2. Consumables
8.3. Instruments
8.4. Services

9. Blood Group Typing Market, by End-User

9.1. Introduction
9.2. Blood Banks
9.3. Clinical Laboratories
9.4. Hospitals

10. Americas Blood Group Typing Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Blood Group Typing Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Blood Group Typing Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. My Personal Health Bank Joins Forces with Eldon Biologicals A/S for Innovative Healthcare Solutions incorporating POC Blood Typing
- 13.3.2. Metropolis Healthcare launches test for HSCT & solid organ transplantation
- 13.3.3. NHSBT Researchers Discover New Blood Group System
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio